Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

87.89
Delayed Data
As of Jul 22
 +3.26 / +3.85%
Today’s Change
47.92
Today|||52-Week Range
103.29
+7.31%
Year-to-Date
Strength Seen in Dexcom (DXCM) Soars: Stock Soars 6.2%
Jul 20 / Zacks.com - Paid Partner Content
Barbarian At The Gate: DexCom (DXCM)
Jul 19 / TheStreet.com - Paid Partner Content
Why MGIC Investment, Dexcom, and F5 Networks Jumped Today
Jul 19 / MotleyFool.com - Paid Partner Content
MedTech Tailwinds at a Glance: Which Stocks to Buy?
Jul 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close84.63
Today’s open87.96
Day’s range86.31 - 89.05
Volume2,155,284
Average volume (3 months)909,808
Market cap$7.3B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)-35.88%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book32.46

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+0.61+0.79%
ABMDAbiomed Inc+0.24+0.21%
NUVANuVasive Inc-0.37-0.60%
IARTIntegra LifeSciences...-0.62-0.78%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs